VETRO, CALOGERO
 Distribuzione geografica
Continente #
NA - Nord America 996
AS - Asia 393
EU - Europa 313
AF - Africa 116
SA - Sud America 53
OC - Oceania 4
Totale 1.875
Nazione #
US - Stati Uniti d'America 978
SG - Singapore 180
IT - Italia 173
CN - Cina 148
CI - Costa d'Avorio 93
IE - Irlanda 59
BR - Brasile 46
KR - Corea 34
UA - Ucraina 18
FI - Finlandia 15
SN - Senegal 15
DE - Germania 12
CA - Canada 10
IN - India 8
CZ - Repubblica Ceca 6
MX - Messico 6
VN - Vietnam 6
GB - Regno Unito 5
AU - Australia 4
BE - Belgio 4
NG - Nigeria 4
SE - Svezia 4
HK - Hong Kong 3
IQ - Iraq 3
RO - Romania 3
TR - Turchia 3
ZA - Sudafrica 3
AR - Argentina 2
BD - Bangladesh 2
BO - Bolivia 2
CH - Svizzera 2
FR - Francia 2
GR - Grecia 2
NL - Olanda 2
PL - Polonia 2
AT - Austria 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
HN - Honduras 1
IL - Israele 1
JP - Giappone 1
KE - Kenya 1
LT - Lituania 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.875
Città #
Dallas 224
Santa Clara 167
Houston 164
Singapore 129
Abidjan 93
Chicago 78
Hefei 66
Chandler 57
Dublin 57
Ashburn 38
Civitanova Marche 35
Seoul 34
Boardman 28
Beijing 21
Rome 21
Los Angeles 17
Dakar 15
Florence 14
Cambridge 12
Catania 12
Lawrence 12
Milan 12
Jacksonville 10
Andover 8
Helsinki 7
Munich 7
Falls Church 6
New York 6
Palermo 6
Lappeenranta 5
Piazzola Sul Brenta 5
Wilmington 5
Abuja 4
Brussels 4
Chennai 4
Dong Ket 4
Nanjing 4
Stockholm 4
São Paulo 4
Toronto 4
Brno 3
Des Moines 3
Hong Kong 3
Lamezia Terme 3
Melbourne 3
Olomouc 3
San Francisco 3
Seattle 3
Turku 3
Atlanta 2
Belo Horizonte 2
Boston 2
Campinas 2
Cernusco sul Naviglio 2
Charlotte 2
Council Bluffs 2
Frankfurt am Main 2
Ho Chi Minh City 2
Jiaxing 2
Kochi 2
London 2
Manassas 2
Melilli 2
Messina 2
Misterbianco 2
Nanchang 2
Porto Alegre 2
The Dalles 2
Trecastagni 2
Veracruz 2
Warsaw 2
Washington 2
Afogados da Ingazeira 1
Alterosa 1
Armação dos Búzios 1
Assis 1
Asunción 1
Augusta 1
Baqubah 1
Barbacena 1
Barueri 1
Belgrade 1
Belpasso 1
Bismarck 1
Bremen 1
Bronte 1
Changsha 1
Cochabamba 1
Columbus 1
Cosenza 1
Cotia 1
Curitiba 1
Denver 1
Divinópolis 1
Durban 1
Dushanbe 1
Easton 1
Edinburgh 1
Elesbão Veloso 1
Elizabethtown 1
Totale 1.504
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 242
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance 105
A case of high-risk AML in a patient with advanced systemic mastocytosis 98
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 90
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 86
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 85
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database 83
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 81
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field 80
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 80
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 73
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 69
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters 69
Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough? 67
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data 64
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes 64
VEXAS-like syndrome: a potential new entity? 62
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 60
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature 59
Advances in understanding regulatory myeloid cells 57
Therapeutic innovation for multi-resistant candidemics: synergy of isavuconazole and caspofungin association 55
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors 51
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 50
Emerging Therapeutic Approaches for Anemia in Myelofibrosis 46
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients 30
Totale 1.906
Categoria #
all - tutte 7.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202119 0 0 0 2 7 0 2 0 1 0 2 5
2021/2022102 4 5 0 0 14 7 14 3 10 14 5 26
2022/2023218 14 20 10 14 11 23 7 43 53 3 12 8
2023/2024236 10 39 10 21 5 51 18 19 3 8 36 16
2024/2025629 7 121 27 59 121 73 21 19 35 39 56 51
2025/2026510 90 180 223 17 0 0 0 0 0 0 0 0
Totale 1.906